A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.
Calvo E, Doger B, Carles J, Peer A, Sarid D, Eigl BJ, Avadhani A, Yao D, Lin V, Wu S, Jaiprasart P, Loffredo J, Tamegnon M, Xu W, Xie H, Hansen AR.
Calvo E, et al. Among authors: yao d.
Oncologist. 2025 Jan 17;30(1):oyae313. doi: 10.1093/oncolo/oyae313.
Oncologist. 2025.
PMID: 39832129
Free PMC article.
Clinical Trial.